NCT00019721View on ClinicalTrials.gov

Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

April 30, 1999

Study Completion Date

June 30, 2003

Conditions
Melanoma (Skin)
Interventions
BIOLOGICAL

MART-1 antigen

BIOLOGICAL

aldesleukin

BIOLOGICAL

gp100 antigen

BIOLOGICAL

incomplete Freund's adjuvant

Trial Locations (1)

20892

Surgery Branch, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH